hPSCreg®
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our Privacy Policy for details. This website uses cookies, learn more

Search results

Sort by:

Filter by:

  1. AHQUi001-A (IPS35-2)

    China Affiliated Hospital of Qingdao University (AHQU)
    Disease:

    Non rare in europe: hyperlipoproteinemia type 4

  2. BCHNi001-A (BCHi001-A)

    China Beijing Children′s Hospital：Department of Nephrology (BCHN)
    Disease:

    Bardet-biedl syndrome

  3. BCHNCi001-A

    China Beijing Children's Hospital, Center of Neurology (BCHNC)
    Disease:

    Early infantile epileptic encephalopathy

  4. BIOi002-A

    China Beijing Institute of Ophthalmology (BIO)
    Disease:

    Autosomal dominant optic atrophy

  5. BIOi003-A (LYN-C1-P6)

    China Beijing Institute of Ophthalmology (BIO)
    Disease:

    Hereditary retinal dystrophy

  6. BIONi010-C-51

    Denmark Bioneer (BION)
    Disease:

    Normal

  7. BIONi010-C-55 (BIONi010-C TNNI3-mCherry/TNNI1-EGFP dual reporter cl. 74)

    Denmark Bioneer (BION)
    Disease:

    Normal

  8. BJTTHi001-A

    China Beijing Tiantan Hospital (BJTTH)
    Disease:

    Normal

  9. BRCi021-A (TUH1)

    Japan RIKEN BioResource Research Center (BRC)
    Disease:

    Cardiomyopathy

  10. CEBe033-A (SA001)

    Sweden Takara Bio Europe AB (former Cellartis) (CEB)
    Disease:

    Normal

  11. CHDIi033-A (#104c2 and CHDI-90002181)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  12. CHDIi034-A (#105c1 and CHDI-90002182)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  13. CHDIi035-A (#108c5 and CHDI-90002183)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  14. CHDIi036-A (#110c5 and CHDI-90002184)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  15. CHDIi038-A (#112c7 and CHDI-90002186)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  16. CHDIi040-A (#115c6 and CHDI-90002188)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  17. CHDIi041-A (#116c2 and CHDI-90002189)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  18. CHDIi042-A (#117c5 and CHDI-90002190)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal

  19. CHDIi043-A (#118c6 and CHDI-90002191)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal

  20. CHDIi044-A (#120c3 and CHDI-90002192)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal

  21. CHDIi045-A (#121c6 and CHDI-90002193)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  22. CHDIi046-A (#122c1 and CHDI-90002194)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  23. CHDIi047-A (#123c6 and CHDI-90002195)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal

  24. CHDIi048-A (#125c2 and CHDI-90002196)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  25. CHDIi049-A (#127c2 and CHDI-90002197)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  26. CHDIi050-A (#128c3 and CHDI-90002198)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal

  27. CHDIi051-A (#129c1 and CHDI-90002199)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal

  28. CHDIi054-A (#132c3 and CHDI-90002202)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal

  29. CHDIi055-A (#133c5 and CHDI-90002203)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Huntington disease

  30. CHDIi056-A (#134c3 and CHDI-90002204)

    United States CHDI Foundation Inc. (CHDI)
    Disease:

    Normal

  31. CIPi001-A

    China Children’s Hospital of Capital Institute of Pediatrics (CIP)
    Disease:

    Benign familial infantile epilepsy

  32. CIRAi006-A (F2KU2#17 and F2KU2)

    Japan Center for iPS Cell Research and Application (CIRA)
    Disease:

    Facioscapulohumeral muscular dystrophy 2

  33. CPGHi004-A

    China Chinese PLA General Hospital (CPGH)
    Disease:

    Normal

  34. CPGHi006-A

    China Chinese PLA General Hospital (CPGH)
    Disease:

    Autosomal dominant polycystic kidney disease

  35. CPGHi007-A

    China Chinese PLA General Hospital (CPGH)
    Disease:

    Normal

  36. CPGHi008-A

    China Chinese PLA General Hospital (CPGH)
    Disease:

    Autosomal recessive polycystic kidney disease

  37. FINCBi004-A

    Italy Fondazione IRCCS Istituto Neurologico C. Besta (FINCB)
    Disease:

    Neurodegeneration with brain iron accumulation 4

  38. FJMUUHi001-A

    China Fujian Medical University Union Hospital (FJMUUH)
    Disease:

    Parkinson's disease 7

  39. GWCMCi001-A (iPS-57)

    China Guangzhou Women and Children's Medical Center (GWCMC)
    Disease:

    Iga glomerulonephritis

  40. HKUi002-A (AYC12 and HKUi002-A-AYC12)

    Hong Kong The University of Hong Kong (HKU)
    Disease:

    Dilated cardiomyopathy

  41. HMGUi004-A

    Germany Helmholtz Zentrum München (HMGU)

  42. HNMUi002-A (iPS-UC1291)

    China Hainan Medical University (HNMU)
    Disease:

    Thalassemia

  43. HNMUi003-A (iPS-UC1290)

    China Hainan Medical University (HNMU)
    Disease:

    Thalassemia

  44. HNMUi004-A (iPS-AF717)

    China Hainan Medical University (HNMU)
    Disease:

    Thalassemia

  45. HNMUi005-A (iPS-UC1056)

    China Hainan Medical University (HNMU)
    Disease:

    Thalassemia

  46. HNMUi006-A (iPS-UC1055)

    China Hainan Medical University (HNMU)
    Disease:

    Thalassemia

  47. HNMUi007-A (iPS-AF0442)

    China Hainan Medical University (HNMU)
    Disease:

    Thalassemia

  48. HNMUi008-A (iPS-UC2419)

    China Hainan Medical University (HNMU)
    Disease:

    Thalassemia

  49. HNMUi009-A (iPS-UC1171)

    China Hainan Medical University (HNMU)
    Disease:

    Thalassemia

  50. HNMUi010-A (iPS-AF091)

    China Hainan Medical University (HNMU)
    Disease:

    Thalassemia

  51. IAIi002-A (IAIi002RSTS1-34-A)

    Italy Istituto Auxologico Italiano IRCCS (IAI)
    Disease:

    Rubinstein-taybi syndrome

  52. HMGUi001-A-4 (hiPSC-ARX-T2A-H2B-CFP-Flag)

    Germany Institute of Diabetes and Regeneration Research (IDR)
    Disease:

    Normal

  53. IIMCBi003-A (K-Pic1)

    Poland International Institute of Molecular and Cell Biology in Warsaw (IIMCB)
    Disease:

    Normal

  54. IIMCBi004-A (PM-H1)

    Poland International Institute of Molecular and Cell Biology in Warsaw (IIMCB)

  55. IIMCBi005-A (EM-K3)

    Poland International Institute of Molecular and Cell Biology in Warsaw (IIMCB)

  56. IIMCBi006-A (M-T1)

    Poland International Institute of Molecular and Cell Biology in Warsaw (IIMCB)

  57. KAUSTi011-A (iPSC-GLP1R-KO-C1)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Developmental and epileptic encephalopathy

  58. KAUSTi011-B (iPSC-GLP1R-KO-H4)

    Saudi Arabia King Abdullah University of Science and Technology (KAUST)
    Disease:

    Developmental and epileptic encephalopathy

  59. KLRMMEi001-A

    China Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University. (KLRMME)
    Disease:

    Retinitis pigmentosa

  60. KLRMMEi003-A

    China Key Laboratory for Regenerative Medicine of Ministry of Education, Jinan University. (KLRMME)
    Disease:

    Usher syndrome

  61. LCPHi001-A

    China The Institute for Tissue Engineering and Regenerative Medicine, Liaocheng People's Hospital (LCPH)
    Disease:

    Obsolete_parkinson's disease

  62. LCPHi002-A

    China The Institute for Tissue Engineering and Regenerative Medicine, Liaocheng People's Hospital (LCPH)
    Disease:

    Parkinson's disease

  63. LCPHi003-A

    China The Institute for Tissue Engineering and Regenerative Medicine, Liaocheng People's Hospital (LCPH)
    Disease:

    Parkinson's disease

  64. LUMCi039-A (LQT1-1781G/A hiPSC and LUMC0021iKCNQ-30)

    Netherlands Leiden University Medical Center (LUMC)
    Disease:

    Long qt syndrome 1

  65. MCRIi001-A-1 (PB001-OI26)

    Australia Murdoch Children's Research Institute (MCRI)
    Disease:

    Osteogenesis imperfecta

  66. MMCi002-A (MMC-iPSC-002-A)

    Taiwan Mackay Medical College (MMC)
    Disease:

    Hearing loss

  67. MUNIi001-A (DMD02)

    Czech Republic Masaryk University (MUNI)
    Disease:

    Duchenne muscular dystrophy

  68. MUNIi002-A (MDMD02)

    Czech Republic Masaryk University (MUNI)
    Disease:

    Duchenne muscular dystrophy

  69. MUNIi003-A (DMD03)

    Czech Republic Masaryk University (MUNI)
    Disease:

    Duchenne muscular dystrophy

  70. MUNIi004-A (DMD04)

    Czech Republic Masaryk University (MUNI)
    Disease:

    Duchenne muscular dystrophy

  71. PUFHi004-A (TMEM163 c.227T>C p.(Leu76Pro) iPSC)

    China Peking University First Hospital (PUFH)
    Disease:

    Leukodystrophy

  72. PUMCi002-A (AF-iPSCs and C1)

    China Peking Union Medical College (PUMC)
    Disease:

    Normal

  73. CEBe033-A-1 (GBA1_hESC_GBA#1-/-_10.18.11)

    Switzerland F. Hoffmann-La Roche Ltd (ROCHE)
    Disease:

    Gaucher disease

  74. SCMCi001-A

    China Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine (SCMC)
    Disease:

    Normal

  75. SCVIi074-A (SCVIi599C1)

    United States Stanford Cardiovascular Institute (SCVI)
    Disease:

    Hypertrophic cardiomyopathy

  76. SDPHi003-A

    China Shandong Provincial Hospital Affiliated to Shandong First Medical University (SDPH)
    Disease:

    Normal

  77. SDPHi004-A

    China Shandong Provincial Hospital Affiliated to Shandong First Medical University (SDPH)
    Disease:

    Normal

  78. SDZFYi001-A

    China Shandong Academy of Occupational Health and Occupational Medicine (SDZFY)
    Disease:

    Normal

  79. SHCDNRi001-A (IPS-51)

    China Shanghai Children's Hospital, Department of Nephrology and Rheumatology (SHCDNR)
    Disease:

    Alport syndrome

  80. SIAISi011-A (NZM)

    China Shanghai Institute for Advanced Immunochemical Studies (SIAIS) (SIAIS)
    Disease:

    Normal

  81. SKLRMi001-A

    China State Key Laboratory of Reproductive Medicine, Nanjing Medical University (SKLRM)
    Disease:

    Androgen insensitivity syndrome

  82. SZGJMSi001-A (ZLP-2)

    China Research Center of Biological Psychiatry, Suzhou Guangji hospital (SZGJMS)
    Disease:

    Schizophrenia

  83. SZGJMSi002-A (TSQ-1)

    China Research Center of Biological Psychiatry, Suzhou Guangji hospital (SZGJMS)
    Disease:

    Obsessive-compulsive disorder

  84. SZGJMSi003-A (TSH-2)

    China Research Center of Biological Psychiatry, Suzhou Guangji hospital (SZGJMS)
    Disease:

    Normal

  85. SZGJMSi004-A (WJM-1)

    China Research Center of Biological Psychiatry, Suzhou Guangji hospital (SZGJMS)
    Disease:

    Depression

  86. TUSMi001-A

    China Tongji University School of Medicine (TUSM)
    Disease:

    Normal

  87. TUSMi002-A

    China Tongji University School of Medicine (TUSM)
    Disease:

    Normal

  88. TUSMi003-A

    China Tongji University School of Medicine (TUSM)
    Disease:

    Alzheimer's disease

  89. TUSMi004-A

    China Tongji University School of Medicine (TUSM)
    Disease:

    Obsessive-compulsive disorder

  90. TUSMi005-A

    China Tongji University School of Medicine (TUSM)
    Disease:

    Obsolete_bipolar disorder

  91. TUSMi006-A (15M0014)

    China Tongji University School of Medicine (TUSM)
    Disease:

    Obsolete_alzheimer's disease

  92. TUSMi007-A

    China Tongji University School of Medicine (TUSM)
    Disease:

    Alzheimer's disease

  93. TUSMi008-A

    China Tongji University School of Medicine (TUSM)
    Disease:

    Alzheimer's disease

  94. WAe001-A-79 (H1_CTR1-mEos4b)

    United States University of Houston - Main Campus (UHMC)
    Disease:

    Normal

  95. UIOi001-A (AG27)

    Norway University of Oslo (UIO)
    Disease:

    Normal

  96. UNAMi001-A (IFC-UNAM iPD01-S)

    Mexico Instituto de Fisiología Celular, Universidad Nacional Autónoma de México (UNAM)
    Disease:

    Parkinson's disease

  97. WCHi001-A

    China West China Hospital (WCH)
    Disease:

    Normal

  98. WCHi003-A

    China West China Hospital (WCH)
    Disease:

    Schizophrenia

  99. WCHi004-A

    China West China Hospital (WCH)
    Disease:

    Normal

  100. WCHi005-A

    China West China Hospital (WCH)
    Disease:

    Bipolar disorder

  101. WCHi006-A

    China West China Hospital (WCH)
    Disease:

    Schizophrenia

  102. WTSIi001-A (HPSI1213i-pahc_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  103. WTSIi018-B-1 (HPSI0114i-kolf_2-C1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  104. WTSIi037-A (HPSI0114i-zoxy_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  105. WTSIi038-A (HPSI1113i-ieki_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  106. WTSIi046-B (HPSI0214i-wibj_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  107. WTSIi047-B (HPSI0814i-bokz_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  108. WTSIi049-A (HPSI0514i-wiii_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  109. WTSIi049-B (HPSI0514i-wiii_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  110. WTSIi052-A (HPSI1114i-ziyn_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  111. WTSIi053-A (HPSI0413i-corn_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  112. WTSIi054-B (HPSI0413i-nudd_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  113. WTSIi056-A (HPSI0513i-dipe_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  114. WTSIi057-B (HPSI0513i-giuf_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  115. WTSIi059-A (HPSI0513i-uilw_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  116. WTSIi063-A (HPSI0613i-aevs_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  117. WTSIi068-B (HPSI0613i-giuo_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  118. WTSIi069-A (HPSI0613i-hegp_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  119. WTSIi073-A (HPSI0314i-sojd_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  120. WTSIi082-A (HPSI1013i-cups_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  121. WTSIi083-A (HPSI1213i-xuja_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  122. WTSIi085-A (HPSI1113i-eofe_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  123. WTSIi086-A (HPSI0913i-coyi_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  124. WTSIi098-A (HPSI1213i-nekd_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  125. WTSIi102-A (HPSI0413i-iakz_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  126. WTSIi102-B (HPSI0413i-iakz_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  127. WTSIi103-A (HPSI1213i-nusw_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  128. WTSIi104-A (HPSI0513i-coio_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  129. WTSIi104-B (HPSI0513i-coio_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  130. WTSIi105-A (HPSI0313i-airc_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  131. WTSIi105-B (HPSI0313i-airc_66)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  132. WTSIi106-B (HPSI0613i-hikj_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  133. WTSIi109-A (HPSI0413i-coxy_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  134. WTSIi109-B (HPSI0413i-coxy_33)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  135. WTSIi110-A (HPSI0713i-darw_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  136. WTSIi111-A (HPSI0513i-euir_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  137. WTSIi112-A (HPSI0613i-funp_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  138. WTSIi114-A (HPSI0513i-golb_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  139. WTSIi115-A (HPSI0513i-iasn_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  140. WTSIi116-A (HPSI0813i-iicq_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  141. WTSIi117-A (HPSI0613i-liun_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  142. WTSIi118-A (HPSI0813i-meqo_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  143. WTSIi119-A (HPSI0613i-oefg_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  144. WTSIi120-A (HPSI0513i-oeoo_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  145. WTSIi121-A (HPSI0413i-ougl_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  146. WTSIi121-B (HPSI0413i-ougl_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  147. WTSIi122-A (HPSI0413i-peop_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  148. WTSIi123-A (HPSI0713i-qimz_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  149. WTSIi124-A (HPSI0713i-ruyv_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  150. WTSIi124-B (HPSI0713i-ruyv_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  151. WTSIi125-A (HPSI0413i-uahf_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  152. WTSIi126-A (HPSI0913i-vopm_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  153. WTSIi127-A (HPSI0413i-xekf_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  154. WTSIi128-A (HPSI0413i-yuze_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  155. WTSIi129-A (HPSI0613i-zisa_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  156. WTSIi130-A (HPSI0713i-aehn_22)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  157. WTSIi131-A (HPSI0513i-aipt_33)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  158. WTSIi133-A (HPSI0713i-dard_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  159. WTSIi133-B (HPSI0713i-dard_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  160. WTSIi134-B (HPSI0513i-dulv_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  161. WTSIi137-A (HPSI0613i-lizq_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  162. WTSIi137-B (HPSI0613i-lizq_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  163. WTSIi138-A (HPSI0414i-mita_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  164. WTSIi139-A (HPSI1113i-oaaz_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  165. WTSIi140-A (HPSI0613i-oomz_22)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  166. WTSIi141-A (HPSI0613i-qanu_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  167. WTSIi142-A (HPSI0613i-qony_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  168. WTSIi144-A (HPSI0114i-wegi_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  169. WTSIi145-A (HPSI0813i-wots_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  170. WTSIi146-A (HPSI0613i-xosg_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  171. WTSIi168-A (HPSI0214i-poih_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  172. WTSIi168-B (HPSI0214i-poih_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  173. WTSIi169-A (HPSI0614i-miaj_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  174. WTSIi170-A (HPSI1213i-tolg_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  175. WTSIi170-B (HPSI1213i-tolg_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  176. WTSIi171-A (HPSI0914i-zerv_7)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  177. WTSIi171-B (HPSI0914i-zerv_8)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  178. WTSIi172-A (HPSI0914i-laey_6)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  179. WTSIi172-B (HPSI0914i-laey_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  180. WTSIi173-A (HPSI0414i-naju_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  181. WTSIi174-A (HPSI0614i-paab_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  182. WTSIi175-A (HPSI1014i-tixi_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  183. WTSIi176-B (HPSI0714i-iudw_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  184. WTSIi177-A (HPSI0414i-xojn_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  185. WTSIi178-B (HPSI0215i-fawm_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  186. WTSIi179-A (HPSI0314i-wigw_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  187. WTSIi180-A (HPSI0514i-puie_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  188. WTSIi180-B (HPSI0514i-puie_5)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  189. WTSIi181-A (HPSI0514i-rutc_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  190. WTSIi182-A (HPSI0614i-kegd_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  191. WTSIi183-A (HPSI0414i-oaqd_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  192. WTSIi183-B (HPSI0414i-oaqd_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  193. WTSIi184-A (HPSI1014i-qayj_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  194. WTSIi184-B (HPSI1014i-qayj_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  195. WTSIi186-A (HPSI1014i-babz_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  196. WTSIi187-A (HPSI1013i-sita_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  197. WTSIi188-A (HPSI1014i-kefb_1)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  198. WTSIi189-A (HPSI1014i-quls_2)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  199. WTSIi190-A (HPSI0914i-kajh_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  200. WTSIi191-A (HPSI0215i-oilg_3)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Normal

  201. WTSIi632-B (HPSI0316i-vats_4)

    United Kingdom Wellcome Sanger Institute (WTSI)
    Disease:

    Alport syndrome

  202. XWHNi001-A

    China Department of Neurology, Xuan Wu Hospital (XWHN)
    Disease:

    Alzheimer's disease

  203. XWHNi002-A

    China Department of Neurology, Xuan Wu Hospital (XWHN)
    Disease:

    Normal

  204. ZJUi010-A (ZJULLi002-A and 161103SPYLQTFSDC12)

    China Zhejiang University (ZJU)
    Disease:

    Long qt syndrome

  205. ZZUNEUi010-A (CMF001-A)

    China ZhengZhou University- The first affiliated hospital(ZZU) (ZZUNEU)
    Disease:

    Juvenile amyotrophic lateral sclerosis

  206. ZZUNEUi026-A

    China ZhengZhou University- The first affiliated hospital(ZZU) (ZZUNEU)
    Disease:

    Hypertrophic cardiomyopathy

  207. WAe009-A-A

    China ZhengZhou University- The first affiliated hospital(ZZU) (ZZUNEU)
    Disease:

    Dry eye syndrome